8 Nov 2024 • The FDA has proposed removing oral phenylephrine as an over-the-counter nasal decongestant, citing a lack of evidence supporting its effectiveness in treating nasal congestion.

-Despite being widely used, the FDA's review, supported by recommendations from its advisory committee, found that the available evidence does not support phenylephrine's effectiveness in the oral form.

-This decision is focused on efficacy concerns, not safety. The FDA clarified that nasal spray forms of phenylephrine are not impacted.

Consumers are advised to check product labels and consult healthcare professionals for effective alternatives.

Source: U.S Food and Drug Administration Read full story